Robert J. Riley

Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: a direct role for NADPH:cytochrome P450 oxidoreductase.

P. Workman, R. Riley, A. Lewis, 1994, Carcinogenesis.

Initial characterization of the major mouse cytochrome P450 enzymes involved in the reductive metabolism of the hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, SR 4233, WIN 59075).

P. Workman, R. Riley, M. Graham, 1993, Biochemical pharmacology.

DT-diaphorase and cancer chemotherapy.

P. Workman, R. Riley, Paul Workman, 1992, Biochemical pharmacology.